Aflac (AFL) Stock Price, News & Analysis

Company Overview

Aflac Incorporated (NYSE:AFL) is an insurance company specializing in supplemental health and life insurance. Through its policies, the company helps individuals and families manage expenses that may not be fully covered by major medical insurance, including deductibles, copayments and other out-of-pocket costs.

Aflac offers products such as accident, cancer, critical illness, hospital indemnity, dental and vision, disability, life and long-term care insurance. Many of its supplemental policies provide cash benefits directly to policyholders, who can generally use the funds according to their individual needs. The company also provides employee benefits products through workplace-based distribution channels.

Founded in 1955 as American Family Life Assurance Company of Columbus, Aflac serves customers primarily in the United States and Japan. Its U.S. operations focus on supplemental insurance and workplace benefits, while its Japanese operations offer products including medical, cancer, life and other insurance coverage. Virgil R. Miller serves as president and chief executive officer, and Daniel P. Amos serves as executive chairman.

Key Stats

• Today's Range: $120.56 to $123.28
• 50-Day Range: $111.11 to $123.19
• 52-Week Range: $105.43 to $130.22
• Volume: 1.24 million shs
• Average Volume: 1.61 million shs
• Market Capitalization: $61.76 billion
• P/E Ratio: 15.89
• Dividend Yield: 1.98%
• Price Target: $117.20
• Consensus Rating: Hold

Aflac Stock Analysis - MarketRank™

Aflac scored higher than 72% of companies evaluated by MarketBeat, and ranked 390th out of 848 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Aflac has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 4 sell ratings.

Upside/Downside

The consensus price target for Aflac is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Aflac has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 9.23%

Earnings Growth

Earnings for Aflac are expected to grow by 9.23% in the coming year, from $7.04 to $7.69 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Aflac is 15.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.75.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aflac is 15.89, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.04.

Price to Earnings Growth Ratio

Aflac has a PEG Ratio of 1.90. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Aflac has a P/B Ratio of 2.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.34% of the float of Aflac has been sold short.

Short Interest Ratio / Days to Cover

Aflac has a short interest ratio ("days to cover") of 5.17.

Change versus previous month

Short interest in Aflac has recently increased by 0.50%, indicating that investor sentiment is decreasing.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Aflac pays a meaningful dividend of 2.03%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Aflac has been increasing its dividend for 44 years.

Dividend Coverage

The dividend payout ratio of Aflac is 26.15%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Aflac will have a dividend payout ratio of 31.73% next year. This indicates that Aflac will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.69

News Sentiment

Aflac has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Aflac this week, compared to 9 articles on an average week.

Search Interest

Only 9 people have searched for AFL on MarketBeat in the last 30 days. This is a decrease of -10% compared to the previous 30 days.

MarketBeat Follows

4 people have added Aflac to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Aflac insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $83,323,978.00 in company stock.

Percentage Held by Insiders

0.80% of the stock of Aflac is held by insiders.

Percentage Held by Institutions

67.44% of the stock of Aflac is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Record date for 9/1 Dividend: 8/19/2026
• Ex-Dividend for 9/1 Dividend: 8/19/2026
• Dividend Payable: 9/01/2026
• Today: 10/23/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Insurance
• Sub-Industry: Life & Health Insurance
• Current Symbol: NYSE:AFL
• CIK: 4977
• Web: www.aflac.com
• Phone: (706) 323-3431
• Fax: 706-324-6330
• Employees: 12,716
• Year Founded: 1955

Price Target and Rating

• Average Price Target for Aflac: $117.20
• High Price Target: $138.00
• Low Price Target: $101.00
• Potential Upside/Downside: -4.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): $9.33
• Trailing P/E Ratio: 15.89
• Forward P/E Ratio: 17.50
• P/E Growth: 1.9
• Net Income: $3.65 billion
• Net Margins: 26.91%
• Pretax Margin: 32.02%
• Return on Equity: 13.27%
• Return on Assets: 3.34%

Debt

• Debt-to-Equity Ratio: 0.29
• Current Ratio: 0.12
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: $17.16 billion
• Price / Sales: 3.60
• Cash Flow: $9.55 per share
• Price / Cash Flow: 12.90
• Book Value: $56.27 per share
• Price / Book: 2.19

Miscellaneous

• Outstanding Shares: 501,340,000
• Free Float: 497,332,000
• Market Cap: $61.76 billion
• Optionable: Optionable
• Beta: 0.56